To assess the influence of superficial calcium on the early endothelialization (1 month) of the struts of the Xience Skypoint stent (comparing struts with underlying superficial calcium to struts without underlying calcification)
To assess the influence of superficial calcium on the early endothelialization (1 month) of the struts of the Xience Skypoint stent (comparing struts with underlying superficial calcium to struts without underlying calcificatition by opticaL COHERENCE TOMOGRAPHY.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
40
Patients with Xience Skypoint stent implanted after OCT assesment of calcification
Hospital Universitari Vall Hebron
Barcelona, Spain
RECRUITINGMean strut coverage thickness of stent
Mean strut coverage thickness (μ) of the stent struts located over superficial calcium will be compared to the mean strut coverage thickness of the struts in the calcium free frames by Optical Coherence Tomography (OCT).
Time frame: 1 month
Proportion of covered struts
proportion of covered struts (%) lying over superficial calcium compared to the proportion of covered struts in calcium free frames
Time frame: 1 month
Proportion of uncovered struts
Proportion of uncovered struts by OCT at 1 month comparing calcified and non-calcified struts by OCT
Time frame: 1 month
Proportion of acute post PCI malapposition struts
Proportion of acute post PCI malapposition comparing calcified and non-calcified struts by OCT
Time frame: 1 month
Proportion of malapposed struts
Proportion of malapposed struts comparing calcified and non-calcified struts by OCT at 1 month
Time frame: 1 month
Proportion of the resolution of the baseline malapposition struts
Proportion of the resolution of the baseline malapposition struts according to the presence of underlying superficial calcium by OCT at 1 month
Time frame: 1 month
Degree of endothelialization
Difference in mean struck coverage thickness between calcified lesion and no calcified lesion
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Major adverse cardiovascular events (MACE)
Major adverse cardiovascular events (MACE) defined as a composite of all-cause mortality, cardiac death, myocardial infarction, or target vessel revascularization at 6 months
Time frame: 6 months
All Death
Freedom from all Death
Time frame: 6 months
Cardiac Death
Freedom from Cardiac Death
Time frame: 6 months
Myocardial Infarction
Freedom from Myocardial Infarction
Time frame: 6 months
Target Vessel Revascularization
Freedom from Target Vessel Revascularization
Time frame: 6 months